Fundraising FoxCombinati Incorporated
4 known investors
Find your way into Combinati Incorporated
Sign up to find every way you can get introduced to Combinati Incorporated
- Your email: who you already know at Combinati Incorporated, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Combinati Incorporated team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Combinati developed the QuantStudio Absolute Q Digital PCR System, which uses microfluidic array plate (MAP) technology for detection and quantification of nucleic acids, rare mutations, and genome editing events. The platform serves research laboratories for applications such as next-generation sequencing library quantification and CRISPR-Cas9 editing analysis.
Investors · 4
How we know: Band of Angels's portfolio page · Not right? Tell us
How we know: BayMed Venture Partners's portfolio page · Not right? Tell us
Non-dilutive funding · 7 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $772.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2019 | $224.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.8M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $215K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $700K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Combinati Incorporated do?
- Combinati developed the QuantStudio Absolute Q Digital PCR System, which uses microfluidic array plate (MAP) technology for detection and quantification of nucleic acids, rare mutations, and genome editing events. The platform serves research laboratories for applications such as next-generation sequencing library quantification and CRISPR-Cas9 editing analysis.
- Who are Combinati Incorporated's investors?
- Combinati Incorporated's investors include Band of Angels, BayMed Venture Partners, Endurance28, IT-Farm Corporation.